Crescita Therapeutics Inc.

    Crescita Therapeutics Inc.

    TTSX:CTX
    - -
    CAD
    - -
    - -
    14.76P/E
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    0.08
    0.02
    0.27
    0.86
    0.84
    1.07
    0.76
    0.81
    1.14
    0.87
    1.01
    1.12
    1.24
    Basic EPS, GAAP
    -1.39
    -1.35
    -1.32
    -0.82
    0.12
    0.09
    - -
    -0.05
    0.04
    -0.1
    -0.14
    - -
    -0.02
    Free Cash Flow per Basic Share
    -0.89
    -1.22
    -1.46
    -0.54
    -0.08
    0.24
    0.27
    -0.09
    -0.06
    0.1
    0.08
    0.04
    0.08
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -0.17
    -0.22
    1.65
    0.9
    0.9
    1.02
    1.02
    0.98
    1.04
    0.94
    0.83
    0.84
    0.77
    Tangible Book Value per Share
    -0.17
    -0.22
    0.62
    0.23
    0.49
    0.65
    0.8
    0.8
    0.9
    0.84
    0.74
    0.76
    0.71
    Basic Weighted Avg Shares
    10
    11
    13
    14
    20
    21
    21
    21
    21
    20
    19
    19
    19
    Sales/Revenue/Turnover
    1
    - -
    4
    12
    17
    22
    16
    17
    24
    18
    20
    21
    23
    Operating Margin (%)
    -1,623.86
    -3,243.86
    -419.63
    -51.72
    -0.22
    22.24
    9.94
    -4.29
    2.25
    -11.16
    -16.42
    -4.84
    -5.02
    Depreciation Expense
    - -
    - -
    - -
    1
    1
    2
    1
    1
    1
    2
    1
    2
    2
    Net Income, GAAP
    -15
    -15
    -17
    -11
    2
    2
    - -
    -1
    1
    -2
    -3
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    41.67
    92.88
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -1,759.16
    -6,775.44
    -481.85
    -95.41
    14.41
    8.3
    0.24
    -6.59
    3.66
    -11.33
    -14.04
    -0.44
    -1.38
    Working Capital
    -2
    -3
    17
    6
    11
    12
    15
    13
    14
    14
    10
    11
    10
    LT Debt
    - -
    - -
    7
    3
    3
    1
    1
    2
    1
    1
    - -
    - -
    2
    Total Equity
    -2
    -3
    24
    13
    19
    21
    21
    21
    21
    19
    16
    16
    14
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    12.61
    0.49
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    9.77
    0.24
    - -
    - -
    - -
    - -
    - -
    -4.18
    Return on Common Equity (%)
    - -
    - -
    - -
    -61.63
    14.92
    9.25
    0.18
    -5.3
    4.14
    -9.95
    -15.87
    -0.59
    -2.19

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    2
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    19
    19
    19
    Market Capitalization
    9
    9
    14

    Working Capital

    CAD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    Total Current Assets
    16
    16
    16
    Cash, Cash Equivalents & STI
    8
    9
    9
    Accounts Receivable, Net
    2
    2
    2
    Inventories
    5
    5
    4
    Total Current Liabilities
    5
    5
    6
    Payables & Accruals
    5
    4
    5
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -83.36%
    -5.67%
    -1.6%
    Free Cash Flow
    -100.8%
    -99.8%
    -51.95%
    Net Income, GAAP
    -391.74%
    -730.61%
    -96.65%
    Sales/Revenue/Turnover
    176.41%
    8.32%
    7.85%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    5
    4
    4
    7
    20
    2025
    4
    6
    5
    6
    21
    2026
    6
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    -0.03
    -0.05
    -0.05
    - -
    -0.14
    2025
    -0.05
    0.04
    0.04
    - -
    - -
    2026
    -0.06
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business